Related Experiment Video
Updated: Apr 3, 2026
09:09
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
1.6K
Are Pediatricians Complicit in Vitamin K Deficiency Bleeding?
Melissa Weddle1, Allison Empey2, Eric Crossen3
1Department of Pediatrics, Oregon Health & Science University, Portland, Oregon; weddle@ohsu.edu.
Pediatrics
|September 16, 2015
Summary
Parents can decline vitamin K for newborns after counseling, though risks exist. Clinicians must navigate parental requests for unproven oral vitamin K preparations, balancing safety and autonomy.
Area of Science:
- Pediatrics
- Neonatal Care
- Medical Ethics
Background:
- The American Academy of Pediatrics mandates intramuscular vitamin K for newborns to prevent vitamin K deficiency bleeding.
- Vitamin K deficiency bleeding, while rare, can lead to severe complications.
Observation:
- A case study involving parents declining intramuscular vitamin K for their healthy newborn and requesting an oral preparation.
- The situation raises medical and ethical considerations for healthcare providers.
Findings:
- Parents are generally permitted to decline vitamin K after informed counseling, despite potential risks.
- The case highlights the dilemma of honoring parental requests for alternative, unproven vitamin K preparations.
Implications:
- Clinicians must provide thorough counseling on vitamin K benefits and risks.
- Ethical frameworks are needed to address parental autonomy versus standard medical recommendations for newborn care.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
745
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
745
01:30Vitamins
3.0K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
3.0K
01:24Disorders of Hemostasis
2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
377
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
335
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
335
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
474
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
474